Lavaca Capital’s Gilead Sciences GILD Stock Holding History

Lavaca Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$208K	Hold	1,489	–	–	0.04%	102
2025 Q4	$183K	Hold	1,489	–	–	0.03%	105
2025 Q3	$165K	Hold	1,489	–	–	0.03%	105
2025 Q2	$165K	Hold	1,489	–	–	0.06%	107
2025 Q1	$167K	Hold	1,489	–	–	0.07%	108
2024 Q4	$138K	Buy	+1,489	New	+$134K	0.05%	126
2019 Q2	–	Sell	-57	Closed	-$4K	–	187
2019 Q1	$4K	Hold	57	–	–	﹤0.01%	336
2018 Q4	$4K	Buy	+57	New	+$3.98K	﹤0.01%	302

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Lavaca Capital's GILD Position: Q1 2026 in Review

Lavaca Capital held its Gilead Sciences (GILD) position steady in Q1 2026 at 1,489 shares worth $208K. The position accounts for 0.04% of the portfolio, ranked #102.

Lavaca Capital first reported a position in GILD in Q4 2018 and has held it in 8 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Lavaca Capital held 1,489 shares of Gilead Sciences worth $208K as of Q1 2026.
Lavaca Capital left its Gilead Sciences share count unchanged in Q1 2026.
Gilead Sciences made up 0.04% of Lavaca Capital's portfolio in Q1 2026, its #102 holding.
Lavaca Capital first reported a position in Gilead Sciences in Q4 2018 and has held it in 8 quarters since.
2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Lavaca Capital's 13F filing for Q1 2026, filed 13 May 2026.